Astrana Health's stock is deemed pricey per the price multip...

Astrana Health's stock is deemed pricey per the price multiple model. Despite its volatility and high beta potentially offering a buying opportunity, the current price appears to reflect the company's future growth optimism, suggesting it may not be the best entry point.